Review
doi: 10.1056/NEJMcp1001011.
Clinical practice. Calcium kidney stones
Affiliations
- PMID: 20818905
- PMCID: PMC3192488
- DOI: 10.1056/NEJMcp1001011
Item in Clipboard
Review
Clinical practice. Calcium kidney stones
N Engl J Med.
.
No abstract available
Comment in
-
Calcium kidney stones.N Engl J Med. 2010 Dec 16;363(25):2470; author reply 2471. doi: 10.1056/NEJMc1011349. N Engl J Med. 2010. PMID: 21158673 No abstract available.
-
Calcium kidney stones.N Engl J Med. 2010 Dec 16;363(25):2470; author reply 2471. doi: 10.1056/NEJMc1011349. N Engl J Med. 2010. PMID: 21158674 No abstract available.
Similar articles
-
Use of the discriminant index in dynamic treatment to reduce recurrence of calcium oxalate kidney stones.Br J Urol. 1985 Oct;57(5):500-4. doi: 10.1111/j.1464-410x.1985.tb05855.x. Br J Urol. 1985. PMID: 2998532
-
Medical management of nephrolithiasis.J Urol. 1982 Dec;128(6):1157-64. doi: 10.1016/s0022-5347(17)53403-5. J Urol. 1982. PMID: 6759686 Clinical Trial. No abstract available.
-
Consensus development summaries. Prevention and treatment of kidney stones. National Institutes of Health.Conn Med. 1988 Jul;52(7):415-20. Conn Med. 1988. PMID: 3215027 No abstract available.
-
Prevention and treatment of kidney stones.J Urol. 1989 Mar;141(3 Pt 2):804-8. doi: 10.1016/s0022-5347(17)41015-9. J Urol. 1989. PMID: 2645439 Review. No abstract available.
-
Consensus conference. Prevention and treatment of kidney stones.JAMA. 1988 Aug 19;260(7):977-81. JAMA. 1988. PMID: 3294456 Review. No abstract available.
Cited by
-
Evidence for increased renal tubule and parathyroid gland sensitivity to serum calcium in human idiopathic hypercalciuria.Am J Physiol Renal Physiol. 2013 Sep 15;305(6):F853-60. doi: 10.1152/ajprenal.00124.2013. Epub 2013 Jul 17. Am J Physiol Renal Physiol. 2013. PMID: 23863465 Free PMC article.
-
Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial.BMC Nephrol. 2018 Dec 10;19(1):349. doi: 10.1186/s12882-018-1144-6. BMC Nephrol. 2018. PMID: 30526528 Free PMC article. Clinical Trial.
-
miRNA-34a inhibits cell adhesion by targeting CD44 in human renal epithelial cells: implications for renal stone disease.Urolithiasis. 2020 Apr;48(2):109-116. doi: 10.1007/s00240-019-01155-9. Epub 2019 Sep 10. Urolithiasis. 2020. PMID: 31506763
-
Osteopontin phosphopeptide mitigates calcium oxalate stone formation in a Drosophila melanogaster model.Urolithiasis. 2022 Dec 22;51(1):19. doi: 10.1007/s00240-022-01395-2. Urolithiasis. 2022. PMID: 36547746
-
LIFESTYLE RISK FACTORS AND BONE MASS IN RECURRENT STONE-FORMING PATIENTS: A CROSS-SECTIONAL STUDY IN 144 SUBJECTS.Acta Clin Croat. 2019 Sep;58(3):439-445. doi: 10.20471/acc.2019.58.03.06. Acta Clin Croat. 2019. PMID: 31969755 Free PMC article.
References
-
- Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Jr, Curhan GC. Time trends in reported pevalence of kidney stones in the United States:1976–1994. Kid Int. 2003;63:1817–1823. - PubMed
-
- Borghi L, Meschi T, Guerra A, Novarini A. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovascular Pharmacology. 1993;22(Suppl 6):S78–S86. - PubMed
-
- Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. Journal of Urology. 1997;158(6):2069–2073. 158(6) - PubMed
-
- Ettinger B, Citron JT, Livermore B, Dolman LI. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. Journal of Urology. 1988;139:679–684. - PubMed
-
- Ettinger B, Tang A, Citron JT, Livermore B, Williams T. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med. 1986;315:1386–1389. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
